Sanofi SNY
NASDAQ
| 06/30/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | ||
|---|---|---|---|---|---|
| Net Income | 398.94M | -932.44M | 3.28B | 4.47B | |
| Total Depreciation and Amortization | 1.44B | 2.35B | -386.98M | 931.78M | |
| Total Amortization of Deferred Charges | 67.46M | 130.38M | -- | -- | |
| Total Other Non-Cash Items | 2.22B | 372.51M | 778.63M | -3.05B | |
| Change in Net Operating Assets | -686.22M | 2.09B | 716.67M | -695.71M | |
| Cash from Operations | 3.44B | 4.01B | 4.38B | 1.66B | |
| Capital Expenditure | -1.03B | -2.05B | 987.90M | -959.01M | |
| Sale of Property, Plant, and Equipment | 493.15M | 985.99M | -507.40M | 492.56M | |
| Cash Acquisitions | -1.55B | -10.94B | 628.98M | -610.59M | |
| Divestitures | -- | -- | -- | -- | |
| Other Investing Activities | 1.66B | 9.52B | -11.68B | 11.86B | |
| Cash from Investing | -424.52M | -2.48B | -10.57B | 10.79B | |
| Total Debt Issued | 4.26B | 5.56B | -6.32B | 6.32B | |
| Total Debt Repaid | -1.65B | -4.06B | 1.98B | -1.98B | |
| Issuance of Common Stock | 18.00M | 177.00M | 4.00B | 29.00M | |
| Repurchase of Common Stock | -1.01B | -5.03B | -29.00M | -4.00B | |
| Issuance of Preferred Stock | -- | -- | -- | -- | |
| Repurchase of Preferred Stock | -- | -- | -- | -- | |
| Total Dividends Paid | -5.73B | -5.56B | -- | -5.42B | |
| Other Financing Activities | 1.50B | 5.55B | -5.56B | 517.00M | |
| Cash from Financing | -2.10B | -2.99B | -1.34B | -4.42B | |
| Foreign Exchange rate Adjustments | 11.63M | 8.15M | -14.03M | -24.97M | |
| Miscellaneous Cash Flow Adjustments | -- | 0.00 | 0.00 | 364.31M | |
| Net Change in Cash | 930.46M | -1.45B | -7.54B | 8.36B | |